These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
107 related articles for article (PubMed ID: 5444549)
1. Clinical observations on the use of debrisoquine sulphate (Declinas) in the treatment of hypertension. Heffernan AG; Carty AT Ir J Med Sci; 1970 Jan; 3(1):37-43. PubMed ID: 5444549 [No Abstract] [Full Text] [Related]
2. [Therapeutic effects of debrisoquine sulfate in hypertension]. Liu HW; Chen CY Taiwan Yi Xue Hui Za Zhi; 1972 Mar; 71(3):189-95. PubMed ID: 4506851 [No Abstract] [Full Text] [Related]
4. Debrisoquine sulphate--a new antihypertensive agent with minimal side-effects. Chen BT Singapore Med J; 1971 Apr; 12(2):106-9. PubMed ID: 4945291 [No Abstract] [Full Text] [Related]
5. Letter: Debrisoquine, guanethidine, and bethanidine in hypertension. Talbot S; O'Malley BC; Bing RH Br Med J; 1975 May; 2(5965):278. PubMed ID: 1131592 [No Abstract] [Full Text] [Related]
6. Interaction between debrisoquine and phenylephrine. Aminu J; D'Mello A; Vere DW Lancet; 1970 Oct; 2(7679):935-6. PubMed ID: 4097321 [No Abstract] [Full Text] [Related]
7. Potentiation of hypotensive effect of debrisoquine by insulin. Hume L Diabet Med; 1985 Sep; 2(5):390-1. PubMed ID: 2951097 [TBL] [Abstract][Full Text] [Related]
8. Debrisoquine. A five-year study of a new hypotensive agent. Bauer GE Med J Aust; 1970 Nov; 2(20):911-5. PubMed ID: 5486292 [No Abstract] [Full Text] [Related]
9. Debrisoquin sulfate: a clinical evaluation of a new antihypertensive agent. Blechman M; Sokol C; Moser M Curr Ther Res Clin Exp; 1969 Feb; 11(2):71-6. PubMed ID: 4975816 [No Abstract] [Full Text] [Related]
10. [New antihypertensive drugs. II. Debrisoquin or Declinax]. Amery A; Deruyttere M; Fagard R; Koninckx P Acta Clin Belg; 1970; 25(5):317-34. PubMed ID: 5513889 [No Abstract] [Full Text] [Related]
11. Clinical observations on the effects of debrisoquine sulphate in patients with high blood-pressure. Athanassiadis D; Cranston WI; Juel-Jensen BE; Oliver DO Br Med J; 1966 Sep; 2(5516):732-5. PubMed ID: 5917391 [No Abstract] [Full Text] [Related]
13. [Clinical experience with a new postganglionie blockader (Debriosquin, R0-5-3307)]. Ocon Pujadas J Rev Clin Esp; 1972 Jun; 125(6):521-32. PubMed ID: 5074965 [No Abstract] [Full Text] [Related]
14. [Long-term treatment of hypertension with debrisoquin sulfate]. Hammarström S Lakartidningen; 1970 Jun; 67(23):2663-8. PubMed ID: 5450560 [No Abstract] [Full Text] [Related]
15. Clinical evaluation of Declinax in Nigerian hypertensives. Cole TO; Adadevoh BK Br J Clin Pract; 1970 Jun; 24(6):245-9. PubMed ID: 5456743 [No Abstract] [Full Text] [Related]
16. [Clinical evaluation of a new pharmacological association with hypotensive effect. Statistical presentation of results]. Garetto G Minerva Med; 1973 Apr; 64(21):1083-93. PubMed ID: 4574202 [No Abstract] [Full Text] [Related]
17. Safety and efficacy of quinapril in hypertensive geriatric patients. Howes LG; Nguyen T; Jackson B J Am Geriatr Soc; 1996 Sep; 44(9):1135. PubMed ID: 8790251 [No Abstract] [Full Text] [Related]
18. The position of beta-blockers in antihypertensive therapy. Comparison with other antihypertensive agents. Brunner HR; Waeber B; Ferguson RK; Turini GA; Gavras H Cardiology; 1979; 64 Suppl 1():88-95. PubMed ID: 42489 [No Abstract] [Full Text] [Related]
19. A comparison of debrisoquine and methyldopa in hypertension. Pörsti P Ann Clin Res; 1976 Feb; 8(1):55-62. PubMed ID: 779588 [TBL] [Abstract][Full Text] [Related]